NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 2 filers reported holding NPS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $40,000 | – | 1,122 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVEY CAPITAL MANAGEMENT INC | 431,525 | $11,219,000 | 4.40% |
Palo Alto Investors LP | 1,699,562 | $44,189,000 | 3.30% |
FCG ADVISORS, LLC | 133,504 | $4,116,000 | 2.71% |
SECTORAL ASSET MANAGEMENT INC | 1,726,824 | $44,897,000 | 1.89% |
Rhenman & Partners Asset Management AB | 224,000 | $5,824,000 | 1.70% |
BENDER ROBERT & ASSOCIATES | 75,090 | $1,952,000 | 1.36% |
Penn Capital Management Company, LLC | 1,035,144 | $26,914,000 | 1.12% |
NEXT CENTURY GROWTH INVESTORS LLC | 1,066,148 | $27,719,000 | 0.98% |
EMERALD MUTUAL FUND ADVISERS TRUST | 391,281 | $10,173,000 | 0.98% |
SCHOLTZ & COMPANY, LLC | 31,990 | $832,000 | 0.82% |